质子泵抑制剂：巴雷特食管的罪魁祸首？ - Suppr

Suppr

超能文献

Proton Pump Inhibitors: The Culprit for Barrett's Esophagus?

作者信息

Alsalahi Omran, Dobrian Anca D

机构信息

Department of Physiological Sciences, Eastern Virginia Medical School , Norfolk, VA , USA.

出版信息

Front Oncol. 2015 Jan 9;4:373. doi: 10.3389/fonc.2014.00373. eCollection 2014.

DOI:10.3389/fonc.2014.00373

PMID:25621278

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4288325/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ac/4288325/031a4c20d149/fonc-04-00373-g001.jpg

相似文献

Proton Pump Inhibitors: The Culprit for Barrett's Esophagus?

Front Oncol. 2015 Jan 9;4:373. doi: 10.3389/fonc.2014.00373. eCollection 2014.

The Role of Acid Suppression in Barrett's Esophagus.

Am J Med. 2017 May;130(5):525-529. doi: 10.1016/j.amjmed.2016.12.032. Epub 2017 Feb 1.

Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.

Am J Gastroenterol. 2000 Feb;95(2):387-94. doi: 10.1111/j.1572-0241.2000.01758.x.

The Effect of Proton Pump Inhibitors on Barrett's Esophagus.

Gastroenterol Clin North Am. 2015 Jun;44(2):415-24. doi: 10.1016/j.gtc.2015.02.010. Epub 2015 Mar 18.

Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.

Surg Endosc. 2015 Dec;29(12):3528-34. doi: 10.1007/s00464-015-4103-3. Epub 2015 Feb 13.

Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.

Am J Gastroenterol. 2001 Feb;96(2):331-7. doi: 10.1111/j.1572-0241.2001.03515.x.

Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.

J Gastrointest Surg. 1998 Jul-Aug;2(4):333-41. doi: 10.1016/s1091-255x(98)80072-3.

Gastroesophageal reflux disease and Barrett's esophagus.

Endoscopy. 2001 Feb;33(2):109-18. doi: 10.1055/s-2001-11669.

Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus.

Hum Pathol. 1997 Sep;28(9):1007-9. doi: 10.1016/s0046-8177(97)90052-6.

Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.

Curr Opin Gastroenterol. 2016 Jul;32(4):319-24. doi: 10.1097/MOG.0000000000000274.

引用本文的文献

Pathogenesis of pepsin-induced gastroesophageal reflux disease with advanced diagnostic tools and therapeutic implications.

Front Med (Lausanne). 2025 Feb 19;12:1516335. doi: 10.3389/fmed.2025.1516335. eCollection 2025.

sp. Facilitate the Repair of DNA Damage Caused by Bile-Induced Reactive Oxygen Species in Experimental Models of Gastroesophageal Reflux Disease.

Antioxidants (Basel). 2023 Jun 21;12(7):1314. doi: 10.3390/antiox12071314.

Topical Alginate Protection against Pepsin-Mediated Esophageal Damage: E-Cadherin Proteolysis and Matrix Metalloproteinase Induction.

Int J Mol Sci. 2023 Apr 27;24(9):7932. doi: 10.3390/ijms24097932.

The Protease Inhibitor Amprenavir Protects against Pepsin-Induced Esophageal Epithelial Barrier Disruption and Cancer-Associated Changes.

Int J Mol Sci. 2023 Apr 5;24(7):6765. doi: 10.3390/ijms24076765.

Effects of proton pump inhibitor use on the esophageal microbial community.

BMC Gastroenterol. 2020 Sep 23;20(1):312. doi: 10.1186/s12876-020-01460-3.

Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction.

Hum Pathol. 2020 Nov;105:67-73. doi: 10.1016/j.humpath.2020.08.007. Epub 2020 Sep 14.

Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.

Sci Rep. 2020 Jan 21;10(1):866. doi: 10.1038/s41598-020-57612-8.

Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.

BMJ Open. 2018 Jul 7;8(7):e021869. doi: 10.1136/bmjopen-2018-021869.

Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.

PLoS One. 2017 Jan 10;12(1):e0169691. doi: 10.1371/journal.pone.0169691. eCollection 2017.

Esophageal cancer: The latest on chemoprevention and state of the art therapies.

Pharmacol Res. 2016 Nov;113(Pt A):236-244. doi: 10.1016/j.phrs.2016.08.021. Epub 2016 Aug 24.

本文引用的文献

Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.

Clin Gastroenterol Hepatol. 2015 Apr;13(4):623-34. doi: 10.1016/j.cgh.2014.03.036. Epub 2014 Jun 2.

Risk factors associated with Barrett's epithelial dysplasia.

World J Gastroenterol. 2014 Apr 21;20(15):4353-61. doi: 10.3748/wjg.v20.i15.4353.

Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.

Aliment Pharmacol Ther. 2014 May;39(9):984-91. doi: 10.1111/apt.12693. Epub 2014 Mar 11.

Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.

World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):27-39. doi: 10.4292/wjgpt.v5.i1.27.

Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?

Dig Dis. 2014;32(1-2):156-63. doi: 10.1159/000357184. Epub 2014 Feb 28.

Association between Helicobacter pylori and Barrett's esophagus: a case-control study.

Am J Gastroenterol. 2014 Mar;109(3):357-68. doi: 10.1038/ajg.2013.443. Epub 2014 Jan 14.

Proton pump inhibitor therapy and potential long-term harm.

Curr Opin Endocrinol Diabetes Obes. 2014 Feb;21(1):3-8. doi: 10.1097/MED.0000000000000031.

Bile acid at low pH reduces squamous differentiation and activates EGFR signaling in esophageal squamous cells in 3-D culture.

J Gastrointest Surg. 2013 Oct;17(10):1723-31. doi: 10.1007/s11605-013-2287-1. Epub 2013 Aug 7.

Relationships of CDXs and apical sodium-dependent bile acid transporter in Barrett's esophagus.

World J Gastroenterol. 2013 May 14;19(18):2736-9. doi: 10.3748/wjg.v19.i18.2736.

Bile acid promotes intestinal metaplasia and gastric carcinogenesis.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2101-7. doi: 10.1158/1055-9965.EPI-12-0730. Epub 2012 Sep 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验